Seniors
WASHINGTON, D.C. – Today, U.S. Representatives Marc Veasey (TX-33), Angie Craig (MN-02) Gwen Moore, (WI-04), and Joe Morelle (NY-25) introduced legislation that would use savings from Medicare prescription drug negotiations to lower Medicare Part D costs for low-income seniors.
WASHINGTON, DC – Today, Congressman Veasey (TX-33) joined his colleagues to pass the Patient Protection and Affordable Care Enhancement Act—a bold legislative package that builds on the Affordable Care Act to lower health costs and prescription drug prices for all Americans. The legislation includes provisions to increase health care access and includes a measure similar to one led by Congressman Marc Veasey (TX-33) that would incentivize states to expand Medicaid.
WASHINGTON – Today, Congressman Marc Veasey (TX-33) and Members of the Texas Congressional Delegation urged Governor Greg Abbott to take additional steps to allow cities and counties to institute enforceable stay-at-home orders at their discretion. Governor Abbott has pursued one of the most aggressive economic reopening strategies in the United States that has resulted in skyrocketing COVID-19 cases and hospitalizations in Texas.
WASHINGTON, DC – In the wake of the Coronavirus pandemic, Congressmen Marc Veasey (TX-33) and Ed Perlmutter (CO-07) wrote a letter urging the Food and Drug Administration to ensure availability of existing drugs that have shown promise to combat the spread of the Coronavirus. Specifically, the letter requests information regarding the obstacles to procurement for chloroquine phosphate and hydroxychloroquine—compounds that are both potential broad-spectrum antiviral drugs that researchers say could prevent the spread of Coronavirus.
Washington, D.C. – Representative Marc Veasey (D-TX) along with Reps. Michael C. Burgess, M.D. (R-TX), Lizzie Fletcher (D-TX), and Pete Olson (R-TX), led the entire Texas House Congressional Delegation to protect Medicaid funds for Texas hospitals by sending a letter to the Centers for Medicare and Medicaid Services (CMS) highlighting several concerns over a proposed rule aimed at altering Medicaid financing, that would detrimentally impact Texas.
WASHINGTON, D.C. – Congressman Marc Veasey (TX-33) of the Energy & Commerce and the Small Business Committees released the statement following today after he joined his colleagues to pass a bipartisan spending package:
WASHINGTON, D.C. – Today, Congressman Marc Veasey (TX-33) joined his colleagues to pass the Elijah E. Cummings Lower Drug Costs Now Act, which will help bring down the cost of prescription drugs and level the playing field for American patients who are paying more for their medicines than patients in other countries.
WASHINGTON, D.C. – Congressman Marc Veasey (TX-33) of the Energy and Commerce Committee released the following statement after joining his colleagues on the full Committee to advance crucial legislation that will improve health care coverage for all Americans by lowering prescription drug costs and strengthening Medicare for beneficiaries:
WASHINGTON – Congressmen Marc Veasey (TX-33), Max Rose (NY-11) and Joe Morelle (NY-25), introduced legislation this week that would use savings from Medicare prescription drug negotiations to lower Medicare Part D costs for low-income seniors.
H.R. 4620, the More Help for Seniors Act of 2019, would raise the income limits for eligibility under the Medicare Part D low-income subsidy program, which would help low-income seniors and individuals with disabilities afford needed medications by lowering copays and premiums for Medicare Part D.
Washington, D.C. – Yesterday, Representative Marc Veasey (TX-33) of the Energy and Commerce Committee joined his colleagues of the full Committee to advance eight bipartisan pieces of legislation to ensure our nation's health care is both affordable and accessible.
The package of bills included legislation to reauthorize public health and Medicare programs, improve drug pricing transparency and protect patients from surprise medical bills. Representative Veasey released the following statement after the passage by the full Committee: